https://old.international-biopharma.com/genetic-study-reveals-possible-new-routes-to-treating-osteoarthritis/ 2019-01-28T09:50:55+00:00 https://old.international-biopharma.com/study-may-explain-why-once-promising-cancer-drugs-failed/ 2019-01-28T09:48:34+00:00 https://old.international-biopharma.com/crispr-therapeutics-and-probiogen-sign-collaboration-and-license-agreement-to-develop-novel-in-vivo-delivery-technologies/ 2019-01-28T09:46:08+00:00 https://old.international-biopharma.com/tc-biopharm-creates-allogeneic-cell-banks-for-car-t-cancer-therapy-products/ 2019-01-28T09:42:41+00:00 https://old.international-biopharma.com/genmab-announces-initiation-of-u-s-fda-regulatory-submission-for-label-expansion-of-daratumumab-in-combination-with-lenalidomide-and-dexamethasone-in-front-line-multiple-myeloma/ 2019-01-28T09:41:43+00:00 https://old.international-biopharma.com/cobra-biologics-appoints-dr-darrell-sleep-as-director-of-innovation/ 2019-01-28T09:39:55+00:00 https://old.international-biopharma.com/new-combined-diagnostic-and-antimicrobial-susceptibility-test-enables-resistance-guided-therapy-for-gonorrhoea/ 2019-01-28T09:38:31+00:00 https://old.international-biopharma.com/protein-engineering-extends-the-language-of-immune-cells/ 2019-01-28T09:35:57+00:00 https://old.international-biopharma.com/horizon-discovery-extends-crispr-screening-service-to-primary-human-t-cells/ 2019-01-28T09:33:18+00:00 https://old.international-biopharma.com/pci-pharma-services-announces-a-more-than-20-million-expansion-of-biotech-technologies-including-advanced-injectable-delivery-forms-2/ 2019-01-22T10:59:49+00:00 https://old.international-biopharma.com/wp-content/uploads/2019/01/PCI-Syringe-assembly-2-scaled-1.jpg https://old.international-biopharma.com/wp-content/uploads/2019/01/PCI-invests-in-automated-assembly-of-autoinjectors-300dpi-1.jpg https://old.international-biopharma.com/celgene-strikes-obsidian-deal-to-boost-car-t-options/ 2019-01-21T09:46:34+00:00 https://old.international-biopharma.com/muscle-stem-cells-can-drive-cancer-that-arises-in-duchenne-muscular-dystrophy/ 2019-01-21T09:42:52+00:00 https://old.international-biopharma.com/mundipharma-expands-osteoarthritis-gene-therapy-to-more-apac-countries/ 2019-01-21T09:40:10+00:00 https://old.international-biopharma.com/fda-to-bulk-up-cell-and-gene-therapy-staff-growing-with-the-field/ 2019-01-21T09:38:27+00:00 https://old.international-biopharma.com/minoryx-therapeutics-extends-its-activities-in-belgium/ 2019-01-21T09:37:28+00:00 https://old.international-biopharma.com/novo-nordisk-pharmatech-a-s-signs-distribution-agreement-with-dksh-for-eleven-markets-in-asia-pacific/ 2019-01-17T14:46:54+00:00 https://old.international-biopharma.com/scientists-highlight-lack-of-diversity-in-genomic-studies/ 2019-01-14T10:12:57+00:00 https://old.international-biopharma.com/adding-a-switch-to-cas9-to-make-crispr-gene-editing-safer/ 2019-01-14T10:02:03+00:00 https://old.international-biopharma.com/researchers-uncover-new-mechanism-of-gene-regulation-involved-in-tumor-progression/ 2019-01-14T09:59:14+00:00 https://old.international-biopharma.com/stem-cell-study-offers-clues-for-optimizing-bone-marrow-transplants-and-more/ 2019-01-14T09:58:25+00:00 https://old.international-biopharma.com/medpharm-announces-expansion-of-us-center-of-excellence/ 2019-01-14T09:56:32+00:00 https://old.international-biopharma.com/orchard-therapeutics-highlights-recent-accomplishments-and-2019-strategic-priorities-as-a-global-leader-in-gene-therapy/ 2019-01-14T09:54:50+00:00 https://old.international-biopharma.com/novartis-cell-therapy-ambitions-outpace-early-returns/ 2019-01-14T09:53:04+00:00 https://old.international-biopharma.com/article-on-in-vitro-methods-published-in-ibi/ 2019-01-10T15:33:05+00:00 https://old.international-biopharma.com/wp-content/uploads/2019/01/in-vitro.jpg https://old.international-biopharma.com/bluebird-bio-appoints-nicola-redfern-as-general-manager-for-uk/ 2019-01-09T15:13:53+00:00 https://old.international-biopharma.com/pci-pharma-services-announces-a-more-than-20-million-expansion-of-biotech-technologies-including-advanced-injectable-delivery-forms/ 2019-01-07T16:54:24+00:00 https://old.international-biopharma.com/blocking-brain-inflammation-in-multiple-sclerosis-with-gut-immune-cells/ 2019-01-07T09:51:09+00:00 https://old.international-biopharma.com/a-vaccine-for-type-1-diabetes-provention-bio-says-a-human-trial-is-in-sight/ 2019-01-07T09:39:34+00:00 https://old.international-biopharma.com/tackling-triple-negative-breast-cancer-by-blocking-2-key-survival-pathways/ 2019-01-07T09:37:38+00:00 https://old.international-biopharma.com/takeda-takes-another-step-into-cell-therapy-research/ 2019-01-07T09:32:45+00:00 https://old.international-biopharma.com/new-insight-into-aggressive-breast-cancers/ 2019-01-07T09:29:25+00:00 https://old.international-biopharma.com/velabs-therapeutics-to-cooperate-with-biomed-x-in-the-field-of-immunology/ 2019-01-07T09:28:08+00:00 https://old.international-biopharma.com/pediatric-leukemia-super-drug-could-be-developed-in-the-coming-years/ 2019-01-03T10:50:20+00:00 https://old.international-biopharma.com/tumors-backfire-on-chemotherapy/ 2019-01-03T10:46:42+00:00 https://old.international-biopharma.com/researchers-identify-hundreds-of-new-genes-linked-to-blindness-in-lab-mice/ 2019-01-03T10:44:35+00:00 https://old.international-biopharma.com/cell-free-dna-can-be-used-to-predict-biological-age-according-to-a-new-study/ 2019-01-03T10:42:44+00:00 https://old.international-biopharma.com/gene-therapy-could-be-cost-effective-in-sma-but-not-at-4m/ 2019-01-03T10:34:11+00:00 https://old.international-biopharma.com/contextual-genomics-launches-new-liquid-biopsy-test-and-updated-solid-tumor-panel/ 2019-01-03T10:27:37+00:00 https://old.international-biopharma.com/orchard-therapeutics-and-sirion-biotech-announce-licensing-agreement-to-enhance-gene-therapy-manufacturing-efficiency/ 2019-01-03T09:46:48+00:00 https://old.international-biopharma.com/horizon-discovery-group-plc-enters-an-exclusive-partnership-with-c4x-discovery-holdings-plc-to-validate-targets-and-develop-next-generation-oncology-drugs/ 2019-01-03T09:42:08+00:00 https://old.international-biopharma.com/could-a-once-abandoned-obesity-drug-be-revived-in-osteoporosis/ 2018-12-17T10:13:37+00:00 https://old.international-biopharma.com/ideras-tlr9-yervoy-combo-sees-impressive-disease-control-in-pd-1-refractory-melanoma/ 2018-12-17T10:10:07+00:00 https://old.international-biopharma.com/a-is-for-amplify-crispra-used-to-treat-obesity-without-editing-the-genome/ 2018-12-17T09:56:35+00:00 https://old.international-biopharma.com/biogen-backs-away-from-agtc-after-gene-therapy-failure/ 2018-12-17T09:54:12+00:00 https://old.international-biopharma.com/prestige-biopharma-partners-with-cipla-ltd-to-market-key-cancer-biosimilar/ 2018-12-17T09:51:54+00:00 https://old.international-biopharma.com/batavia-biosciences-partners-with-iavi-to-advance-development-of-vaccine-against-lassa-fever/ 2018-12-17T09:51:10+00:00 https://old.international-biopharma.com/orchard-therapeutics-announces-the-build-out-of-new-gene-therapy-manufacturing-facility-in-california/ 2018-12-17T09:49:52+00:00 https://old.international-biopharma.com/harnessing-the-immune-system-for-immuno-therapeutics-and-the-crucial-need-for-translational-approaches-to-safety-assessment-studies/ 2018-12-10T16:35:12+00:00 https://old.international-biopharma.com/illuminating-the-role-of-epidemiology-in-real-world-research/ 2018-12-10T16:32:39+00:00 https://old.international-biopharma.com/the-era-of-pharma-and-biotech-outsourcing-is-here-to-stay/ 2018-12-10T16:30:17+00:00 https://old.international-biopharma.com/an-efficacious-anthrax-vaccine-based-on-a-recombinant-protein/ 2018-12-10T16:27:49+00:00 https://old.international-biopharma.com/pci-continues-to-invest-according-to-market-demand-as-specialist-2-8c-cold-chain-capabilities-become-operational-at-hay-on-wye-uk-site/ 2018-12-10T16:27:38+00:00 https://old.international-biopharma.com/harnessing-the-power-of-epigenetics-in-precision-medicine/ 2018-12-10T16:25:21+00:00 https://old.international-biopharma.com/the-fascinating-world-of-bacteria-pharmaceutical-and-cosmetic-applications/ 2018-12-10T16:22:11+00:00 https://old.international-biopharma.com/the-importance-of-testing-for-pyrogens-in-raw-and-in-process-materials/ 2018-12-10T16:19:32+00:00 https://old.international-biopharma.com/exploring-the-505b2-route-for-systemic-and-regional-therapy-via-pulmonary-delivery/ 2018-12-10T16:16:39+00:00 https://old.international-biopharma.com/primary-sequence-analysis-of-biosimilars/ 2018-12-10T16:13:03+00:00 https://old.international-biopharma.com/approaches-targeting-t-regulatory-cells-in-autoimmune-diseases/ 2018-12-10T16:10:12+00:00 https://old.international-biopharma.com/classification-and-regulation-of-advanced-therapy-medicinal-products/ 2018-12-10T15:59:50+00:00 https://old.international-biopharma.com/patenting-antibodies-at-the-european-patent-office/ 2018-12-10T15:56:55+00:00 https://old.international-biopharma.com/digital-transformation-optimising-the-opportunities-in-life-sciences-rd/ 2018-12-10T15:54:07+00:00 https://old.international-biopharma.com/challenges-of-small-molecule-production/ 2018-12-10T15:51:28+00:00 https://old.international-biopharma.com/the-cell-therapy-supply-chain-and-risk-assessment-considerations/ 2018-12-10T15:44:59+00:00 https://old.international-biopharma.com/ash18-bluebirds-gene-therapy-progress-shadowed-by-mds-case/ 2018-12-10T10:05:09+00:00 https://old.international-biopharma.com/new-parkinsons-disease-drug-target-revealed-through-study-of-fatty-acids/ 2018-12-10T10:01:24+00:00 https://old.international-biopharma.com/mit-engineers-repurpose-wasp-venom-as-an-antibiotic-drug/ 2018-12-10T09:58:19+00:00 https://old.international-biopharma.com/cardiac-cells-integrated-into-microneedle-patches-could-treat-heart-attacks/ 2018-12-10T09:53:27+00:00 https://old.international-biopharma.com/b-cell-lymphoma-new-treatment-option-doubles-survival-time-compared-to-chemotherapy/ 2018-12-10T09:41:46+00:00 https://old.international-biopharma.com/domain-therapeutics-signs-a-multi-target-research-collaboration-and-license-agreement-with-boehringer-ingelheim-on-g-protein-coupled-receptors-gpcrs-for-central-nervous-system-disorders/ 2018-12-10T09:40:11+00:00 https://old.international-biopharma.com/pci-clinical-services-to-showcase-expertise-in-phase-i-clinical-trials-in-australia/ 2018-12-07T15:30:28+00:00 https://old.international-biopharma.com/pci-pharma-services-celebrates-success-at-aspire-blaenau-gwent-shared-apprenticeship-awards/ 2018-12-07T15:24:38+00:00 https://old.international-biopharma.com/eha-and-ebmt-joint-meeting-on-car-t-cells-first-of-its-kind-in-europe/ 2018-12-03T10:03:48+00:00 https://old.international-biopharma.com/when-good-macrophages-go-bad/ 2018-12-03T09:56:35+00:00 https://old.international-biopharma.com/new-technique-for-identifying-small-molecules-may-speed-up-drug-discovery-manufacturing/ 2018-12-03T09:54:45+00:00 https://old.international-biopharma.com/antibiotic-resistance-breakthrough-study-offers-solution/ 2018-12-03T09:48:50+00:00 https://old.international-biopharma.com/outcry-over-gene-edited-babies-grows-as-chinese-researcher-defends-work/ 2018-12-03T09:37:05+00:00 https://old.international-biopharma.com/cannalean-develops-new-cannabidiol-a-stain-alternative-with-fewer-risks/ 2018-12-03T09:33:03+00:00 https://old.international-biopharma.com/americanbio-responds-to-rapid-growth-in-molecular-diagnostic-and-liquid-biopsy-markets-with-new-cutting-edge-manufacturing-facility/ 2018-12-03T09:29:50+00:00 https://old.international-biopharma.com/yposkesi-enters-into-agreement-in-principle-for-strategic-partnership-with-axovant-to-expand-axovants-gene-therapy-manufacturing-capacity/ 2018-12-03T09:25:56+00:00 https://old.international-biopharma.com/cobra-biologics-pall-corporation-and-the-cell-and-gene-therapy-catapult-win-1-5m-innovate-uk-grant-to-investigate-continuous-manufacturing-for-gene-therapies/ 2018-11-29T13:21:33+00:00 https://old.international-biopharma.com/a-llama-antibody-could-be-the-key-to-a-universal-flu-vaccine/ 2018-11-23T13:43:01+00:00 https://old.international-biopharma.com/roivant-takes-aim-at-resistant-infections-with-667-5m-intron-deal/ 2018-11-23T13:36:10+00:00 https://old.international-biopharma.com/genentechs-inhaled-jak1-inhibitor-shows-promise-as-a-localized-treatment-for-asthma/ 2018-11-23T11:50:46+00:00 https://old.international-biopharma.com/tough-to-overcome-obesity-the-gut-microbiome-might-to-blame/ 2018-11-23T11:47:54+00:00 https://old.international-biopharma.com/selvita-announces-presentations-on-cdk8-inhibitor-sel120-at-the-60th-american-society-of-hematology-annual-meeting/ 2018-11-23T11:45:14+00:00 https://old.international-biopharma.com/alize-pharma-3-moves-forward-with-building-a-transatlantic-biopharmaceutical-company-focused-on-rare-endocrine-and-metabolic-diseases/ 2018-11-23T11:42:41+00:00 https://old.international-biopharma.com/pci-clinical-services-announces-site-expansion-to-support-growth-and-flexibility/ 2018-11-19T15:56:55+00:00 https://old.international-biopharma.com/molecular-dna-analysis-could-facilitate-more-accurate-prognosis-treatment-of-aggressive-brain-tumors/ 2018-11-19T10:25:39+00:00 https://old.international-biopharma.com/study-sheds-light-on-mechanisms-that-prevent-autoimmune-attack/ 2018-11-19T10:19:54+00:00 https://old.international-biopharma.com/genetic-link-to-erectile-dysfunction-discovered/ 2018-11-19T10:13:34+00:00 https://old.international-biopharma.com/nebula-genomics-wants-to-sequence-your-entire-genome-for-free-with-one-little-catch/ 2018-11-19T10:08:19+00:00 https://old.international-biopharma.com/biolive-to-merge-with-bioproduction-congress-for-2019-event/ 2018-11-19T09:57:12+00:00 https://old.international-biopharma.com/commercial-prospects-for-immuno-oncology-development-across-oncology-indications-in-untapped-cancer-types-or-in-combinations-says-globaldata/ 2018-11-19T09:51:50+00:00 https://old.international-biopharma.com/sgs-expands-elemental-impurity-testing-services-at-its-laboratory-in-chennai-india/ 2018-11-19T09:47:51+00:00 https://old.international-biopharma.com/adc-bio-secures-additional-equity-round-investment-extra-funding-for-strategic-move-into-downstream-formulation-and-fill-finish-capabilities-and-full-exploitation-of-lock-release-as-new-adc-manufactur/ 2018-11-16T09:59:15+00:00 https://old.international-biopharma.com/tumour-immune-cells-could-aid-cancer-therapies/ 2018-11-12T10:36:21+00:00 https://old.international-biopharma.com/new-genetic-culprit-found-for-early-progressive-hair-loss/ 2018-11-12T10:34:56+00:00 https://old.international-biopharma.com/abeona-inks-deal-with-regenxbio-for-gene-therapy-vector-supply/ 2018-11-12T10:24:10+00:00 https://old.international-biopharma.com/solving-a-century-old-neuroscience-puzzle-may-lead-to-epilepsy-therapy/ 2018-11-12T10:20:04+00:00 https://old.international-biopharma.com/japan-conducts-worlds-first-ips-cell-transplant-for-parkinsons/ 2018-11-12T10:00:20+00:00 https://old.international-biopharma.com/amal-therapeutics-finalises-e29-million-chf-33-2-million-series-b-round/ 2018-11-12T09:56:39+00:00 https://old.international-biopharma.com/retipharma-secures-funding-to-develop-treatments-of-degenerative-eye-disorders/ 2018-11-12T09:55:27+00:00 https://old.international-biopharma.com/icosabutate-latest-data-shows-direct-and-potent-anti-fibrotic-effect-in-both-differentiated-rodent-nash-models-and-human-stellate-cells/ 2018-11-12T09:54:42+00:00 https://old.international-biopharma.com/probiogen-announces-successful-bispecific-glymaxx-development-project-for-zymeworks/ 2018-11-12T09:53:16+00:00 https://old.international-biopharma.com/nus-scientists-find-novel-method-to-cultivate-human-skin-cells-for-grafting/ 2018-11-12T09:50:49+00:00 https://old.international-biopharma.com/ogt-further-expands-global-direct-sales-and-support-into-asia-pacific-region/ 2018-11-12T09:44:59+00:00 https://old.international-biopharma.com/pci-pharma-services-celebrates-significant-milestone-80-serialization-installations-across-global-supply-network-2/ 2018-11-06T15:53:00+00:00 https://old.international-biopharma.com/twenty-years-on-measuring-the-impact-of-human-stem-cells/ 2018-11-05T11:12:36+00:00 https://old.international-biopharma.com/new-dna-tool-can-predict-peoples-height-and-potentially-assess-risk-for-serious-illnesses/ 2018-11-05T10:32:28+00:00 https://old.international-biopharma.com/scientists-discover-kill-code-in-all-cells-that-can-be-triggered-to-destroy-cancer/ 2018-11-05T10:30:09+00:00 https://old.international-biopharma.com/nih-and-fda-call-for-eliminating-involvement-of-rac-in-human-gene-therapy-experiments/ 2018-11-05T10:28:29+00:00 https://old.international-biopharma.com/mice-study-shows-antibiotics-are-not-always-necessary-to-cure-sepsis/ 2018-11-05T10:25:44+00:00 https://old.international-biopharma.com/plasticell-receives-eu-funding-as-part-of-e3-7-million-consortium-to-advance-neurodegenerative-disease-research/ 2018-11-05T10:20:45+00:00 https://old.international-biopharma.com/horizon-discovery-partners-with-biocartis-to-provide-reference-standards-for-recently-launched-idylla-microsatellite-instability-assay/ 2018-11-05T10:19:41+00:00 https://old.international-biopharma.com/pci-pharma-services-celebrates-significant-milestone-80-serialization-installations-across-global-supply-network/ 2018-11-02T15:58:13+00:00 https://old.international-biopharma.com/cobra-biologics-and-the-university-of-leeds-collaborate-in-biopronet-funded-project/ 2018-11-02T15:54:57+00:00 https://old.international-biopharma.com/prostate-cancer-scientists-reveal-new-way-to-target-stubborn-cells/ 2018-10-29T10:36:39+00:00 https://old.international-biopharma.com/disease-causing-mutation-found-in-french-canadians/ 2018-10-29T10:25:51+00:00 https://old.international-biopharma.com/new-human-cell-structure-discovered/ 2018-10-29T10:16:37+00:00 https://old.international-biopharma.com/biogen-advances-research-to-improve-outcomes-for-patients-with-multiple-sclerosis/ 2018-10-29T10:06:13+00:00 https://old.international-biopharma.com/sgs-introduces-new-in-vitro-toxicology-testing-at-its-mississauga-canada-laboratory/ 2018-10-29T10:02:12+00:00 https://old.international-biopharma.com/elpis-biomed-human-cell-models-could-potentially-replace-animal-experiments-in-drug-discovery/ 2018-10-29T09:56:32+00:00 https://old.international-biopharma.com/pci-pharma-services-completes-acquisition-of-sherpa-clinical-packaging/ 2018-10-22T12:26:03+00:00 https://old.international-biopharma.com/wp-content/uploads/2018/10/PCI-Acquires-Sherpa_2-scaled-1.jpg https://old.international-biopharma.com/pci-clinical-services-announces-new-facility-dedicated-to-clinical-trial-returns/ 2018-10-22T12:23:06+00:00 https://old.international-biopharma.com/wp-content/uploads/2018/10/PCI-Clinical-Services-Announces-New-Facility-Dedicated-to-Clinical-Trial-Returns_2_LR.jpg https://old.international-biopharma.com/wp-content/uploads/2018/10/PCI-Clinical-Services-Announces-New-Facility-Dedicated-to-Clinical-Trial-Returns_3_LR.jpg https://old.international-biopharma.com/apceth-biopharma-presents-positive-data-demonstrating-efficacy-of-apceth-201-in-preclinial-models-of-acute-gvhd/ 2018-10-22T09:04:00+00:00 https://old.international-biopharma.com/polyganics-initiates-first-in-human-trial-of-liqoseal-its-innovative-approach-for-dural-closure/ 2018-10-22T09:02:49+00:00 https://old.international-biopharma.com/scientists-engineer-way-to-prevent-immune-response-to-gene-therapy-in-mice/ 2018-10-19T12:40:36+00:00 https://old.international-biopharma.com/this-rna-based-technique-could-make-gene-therapy-more-effective/ 2018-10-19T12:39:27+00:00 https://old.international-biopharma.com/next-generation-als-drug-silences-inherited-form-of-the-disease-in-animal-models/ 2018-10-19T12:37:34+00:00 https://old.international-biopharma.com/researchers-awarded-grant-to-advance-testing-of-experimental-heroin-vaccine/ 2018-10-19T10:49:39+00:00 https://old.international-biopharma.com/eye-scan-a-promising-option-for-early-detection-of-central-nervous-system-disorders/ 2018-10-19T10:40:53+00:00 https://old.international-biopharma.com/basophils-underestimated-players-in-lung-development/ 2018-10-19T10:39:20+00:00 https://old.international-biopharma.com/importance-of-cell-cycle-and-cellular-senescence-in-the-placenta-discovered/ 2018-10-19T10:35:21+00:00 https://old.international-biopharma.com/arcis-biotechnology-and-teleflex-sign-license-agreement/ 2018-10-19T10:32:57+00:00 https://old.international-biopharma.com/apceth-to-manufacture-first-potential-one-time-gene-therapy-for-transfusion-dependent-%ce%b2-thalassemia/ 2018-10-05T15:08:11+00:00 https://old.international-biopharma.com/rare-case-of-car-t-resistance-underscores-manufacturing-hurdles/ 2018-10-05T09:48:46+00:00 https://old.international-biopharma.com/ciprofloxacin-dramatically-affects-the-mitochondrial-genome/ 2018-10-04T14:56:09+00:00 https://old.international-biopharma.com/in-small-patient-group-sareptas-dmd-gene-therapy-gives-some-hope/ 2018-10-04T14:53:06+00:00 https://old.international-biopharma.com/immunotherapy-killer-cells-get-boost-in-fight-against-cancer/ 2018-10-04T14:49:39+00:00 https://old.international-biopharma.com/a-compound-found-in-apples-can-slow-down-aging/ 2018-10-04T14:44:20+00:00 https://old.international-biopharma.com/drug-resistance-trojan-horse-compound-kills-bacteria-from-within/ 2018-10-04T14:34:46+00:00 https://old.international-biopharma.com/arcis-biotechnology-raises-1-25-million-usd-1-63-million-funding-and-opens-further-0-5-million-investment-opportunity-through-capital-cell/ 2018-10-04T14:30:34+00:00 https://old.international-biopharma.com/cphi-annual-report-2018-bio-section-biolive-report-forecast-bioconjugation-expertise-and-increased-productivity-in-bio-over-next-5-years/ 2018-10-04T14:27:48+00:00 https://old.international-biopharma.com/orchard-therapeutics-receives-ema-prime-designation-for-otl-300-an-investigational-lentiviral-gene-therapy-for-the-treatment-of-transfusion-dependent-beta-thalassemia/ 2018-10-04T14:26:11+00:00 https://old.international-biopharma.com/faulty-immune-system-linked-to-uks-leading-cause-of-blindness/ 2018-10-04T14:24:29+00:00 https://old.international-biopharma.com/evonetix-partner-with-lionix-international-to-enable-dna-synthesis-at-scale/ 2018-10-04T14:22:39+00:00 https://old.international-biopharma.com/scientists-develop-recombinant-human-antibody-panel-against-snake-venom/ 2018-10-04T14:21:47+00:00 https://old.international-biopharma.com/gdpr-and-the-implications-on-real-world-research/ 2018-10-03T15:01:51+00:00 https://old.international-biopharma.com/treating-cancer-by-taking-the-brakes-off-the-immune-system-modelling-immune-oncology-drugs-in-preclinical-development/ 2018-10-03T14:59:04+00:00 https://old.international-biopharma.com/situation-critical-antimicrobial-resistance/ 2018-10-03T14:56:24+00:00 https://old.international-biopharma.com/how-to-stem-the-tide-of-data-deluge-to-produce-better-science-in-biopharma-rd/ 2018-10-03T14:53:11+00:00 https://old.international-biopharma.com/applications-of-functional-protein-arrays-for-detection-and-development-of-autoantibody-based-diagnostic-and-therapeutic/ 2018-10-03T14:50:31+00:00 https://old.international-biopharma.com/the-sweet-threat/ 2018-10-03T14:47:02+00:00 https://old.international-biopharma.com/biomanufacturing-process-control/ 2018-10-03T14:44:12+00:00 https://old.international-biopharma.com/biological-sample-catalogues-enabling-biorepository-collaboration-to-foster-effective-research/ 2018-10-03T14:40:56+00:00 https://old.international-biopharma.com/regulatory-convergence-in-european-life-sciences/ 2018-10-03T14:37:53+00:00 https://old.international-biopharma.com/role-and-significance-of-notified-bodies-under-the-new-medical-devices-regulation-and-the-in-vitro-diagnostics-regulation/ 2018-10-03T14:35:12+00:00 https://old.international-biopharma.com/a-look-to-lessons-past-why-biopharma-should-make-use-of-small-molecule-expertise/ 2018-10-03T14:31:35+00:00 https://old.international-biopharma.com/how-to-ensure-the-safety-of-temperature-sensitive-clinical-trial-medication/ 2018-10-03T14:23:51+00:00 https://old.international-biopharma.com/using-blockchain-to-address-interoperability-concerns-in-healthcare/ 2018-10-03T13:05:39+00:00 https://old.international-biopharma.com/dna-islands-effective-as-anti-bacterial-drones/ 2018-10-01T08:36:21+00:00 https://old.international-biopharma.com/new-drug-blocks-pancreatic-cancer-growth-in-mice-study-finds/ 2018-10-01T08:34:31+00:00 https://old.international-biopharma.com/parkinsons-new-molecule-can-stop-neural-damage/ 2018-10-01T08:31:47+00:00 https://old.international-biopharma.com/transplantation-medicine-c-cit-sensors-to-provide-biosensors-for-ex-vivo-liver-perfusion-machine-of-wyss-zurich-project-liver4life/ 2018-10-01T08:26:12+00:00 https://old.international-biopharma.com/cobra-biologics-ge-healthcare-and-centre-for-process-innovation-collaborate-to-advance-gene-therapy/ 2018-10-01T08:24:10+00:00 https://old.international-biopharma.com/biolive-report-forecast-bioconjugation-expertise-and-increased-productivity-in-bio-over-next-5-years/ 2018-10-01T08:19:45+00:00 https://old.international-biopharma.com/crispr-viacyte-team-up-to-develop-stem-cell-therapies-for-diabetes/ 2018-09-24T10:00:42+00:00 https://old.international-biopharma.com/regeneron-expands-immuno-oncology-push-with-bluebird-pact/ 2018-09-24T09:27:56+00:00 https://old.international-biopharma.com/pre-clinical-success-for-a-universal-flu-vaccine-offers-hope-for-third-generation-approach/ 2018-09-24T09:25:08+00:00 https://old.international-biopharma.com/neurimmune-achieves-milestone-in-collaboration-with-ono-pharmaceutical/ 2018-09-24T09:17:03+00:00 https://old.international-biopharma.com/new-research-predicts-a-positive-future-for-biosimilar/ 2018-09-24T09:15:21+00:00 https://old.international-biopharma.com/horizon-discovery-introduces-myeloid-dna-reference-standard-to-support-genetic-testing-of-leukemia/ 2018-09-24T09:13:47+00:00 https://old.international-biopharma.com/pci-and-csp-technologies-inc-announce-strategic-collaboration-for-breakthrough-activ-blistertm-solutions/ 2018-09-21T12:30:38+00:00 https://old.international-biopharma.com/wp-content/uploads/2018/09/Activ-Blister-from-CSP-Technologies-1-scaled-1.jpg https://old.international-biopharma.com/pci-pharma-services-announces-agreement-to-acquire-sherpa-clinical-packaging/ 2018-09-21T11:04:39+00:00 https://old.international-biopharma.com/wp-content/uploads/2018/09/PCI-Acquires-Sherpa-scaled-1.jpg https://old.international-biopharma.com/pci-announces-expansion-of-its-industry-leading-cold-chain-infrastructure-with-dedicated-40c-facility/ 2018-09-21T10:58:07+00:00 https://old.international-biopharma.com/wp-content/uploads/2018/09/PCI-Cold-Chain-facility-Rockford-IL-1-scaled-1.jpeg https://old.international-biopharma.com/novel-deep-learning-drug-discovery-platform-gets-1-million-innovation-boost/ 2018-09-20T13:52:13+00:00 https://old.international-biopharma.com/wp-content/uploads/2018/09/AI-image-1.jpg https://old.international-biopharma.com/caspase-2-enzyme-inhibitor-could-provide-effective-way-to-stop-aggressive-fatty-liver-disease/ 2018-09-17T10:02:55+00:00 https://old.international-biopharma.com/mitochondrial-pathway-found-to-be-involved-in-breast-cancer/ 2018-09-17T09:47:49+00:00 https://old.international-biopharma.com/mouse-study-suggests-new-therapeutic-approach-to-treat-heart-failure/ 2018-09-17T09:16:19+00:00 https://old.international-biopharma.com/variation-in-cancer-causing-kras-mutations-greater-than-thought/ 2018-09-17T09:11:25+00:00 https://old.international-biopharma.com/metrion-biosciences-makes-senior-appointments-to-strengthen-its-drug-discovery-leadership-team/ 2018-09-17T09:02:39+00:00 https://old.international-biopharma.com/bia-separations-expands-with-new-upstream-processing-facility/ 2018-09-17T08:59:06+00:00 https://old.international-biopharma.com/atypical-virus-discovered-to-be-driver-of-certain-kidney-diseases/ 2018-09-17T08:57:44+00:00 https://old.international-biopharma.com/horizon-discovery-edit-r-crrna-libraries-adopted-by-astrazeneca-as-part-of-its-functional-genomics-discovery-platform/ 2018-09-17T08:56:39+00:00 https://old.international-biopharma.com/biocad-and-sph-agree-to-build-a-drug-substance-manufacturing-facility-in-china/ 2018-09-17T08:46:06+00:00 https://old.international-biopharma.com/wp-content/uploads/2018/09/image_2018-09-12_12-58-09-1.png https://old.international-biopharma.com/novo-holdings-invests-chf-6-8-million-in-polyphor-to-accelerate-the-development-of-novel-antibiotics-against-multi-drug-resistant-gram-negative-pathogens/ 2018-09-06T12:52:39+00:00 https://old.international-biopharma.com/metrion-biosciences-and-amri-collaborate-to-offer-ion-channel-drug-discovery-services/ 2018-09-06T12:45:28+00:00 https://old.international-biopharma.com/citoxlab-signs-investment-and-partnership-deal-with-experimental-pharmacology-and-oncology-berlin-buch-gmbh-epo/ 2018-09-06T12:34:51+00:00 https://old.international-biopharma.com/achilles-heel-of-anaplastic-large-cell-lymphoma-alcl-cells-identified/ 2018-09-06T12:30:50+00:00 https://old.international-biopharma.com/opioid-crisis-breakthrough-non-addictive-painkiller-found-effective/ 2018-09-06T12:15:33+00:00 https://old.international-biopharma.com/scientists-inch-closer-to-universal-flu-vaccine/ 2018-09-06T12:14:32+00:00 https://old.international-biopharma.com/mushrooms-of-the-far-east-hold-promise-for-the-anti-cancer-therapy/ 2018-09-06T12:13:54+00:00 https://old.international-biopharma.com/for-first-time-in-40-years-cure-for-acute-leukemia-within-reach/ 2018-09-06T12:12:48+00:00 https://old.international-biopharma.com/new-cancer-treatment-uses-enzymes-to-boost-immune-system-and-fight-back/ 2018-09-06T12:10:47+00:00 https://old.international-biopharma.com/orchard-therapeutics-expands-leadership-team-with-appointments-of-head-of-corporate-communications-and-head-of-human-resources/ 2018-08-31T10:25:57+00:00 https://old.international-biopharma.com/bioascent-appoints-new-directors-of-chemistry-and-biosciences-to-lead-integrated-drug-discovery-services/ 2018-08-31T10:21:32+00:00 https://old.international-biopharma.com/biolive-bio-processing-and-manufacturing-league-table-ranks-us-top-and-china-bottom-despite-bio-boom/ 2018-08-31T10:08:07+00:00 https://old.international-biopharma.com/immunotherapy-advances-spur-new-look-at-cancer-vaccines-2/ 2018-08-28T09:38:56+00:00 https://old.international-biopharma.com/seeking-to-adopt-ai-drugmakers-search-for-right-mix-of-talent/ 2018-08-28T09:36:15+00:00 https://old.international-biopharma.com/csls-seqirus-expects-to-double-flu-vaccine-production-at-nc-plant/ 2018-08-28T09:33:14+00:00